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Abstract
Background: The cause of the high HIV prevalence in sub-Saharan Africa is incompletely understood, with
heterosexual penile-vaginal transmission proposed as the main mechanism. Heterosexual HIV transmission has
been estimated to have a very low probability; but effects of cofactors that vary in space and time may
substantially alter this pattern.
Methods: To test the effect of individual variation in the HIV infectiousness generated by co-infection, we
developed and analyzed a mathematical sexual network model that simulates the behavioral components of a
population from Malawi, as well as the dynamics of HIV and the co-infection effect caused by other infectious
diseases, including herpes simplex virus type-2, gonorrhea, syphilis and malaria.
Results: The analysis shows that without the amplification effect caused by co-infection, no epidemic is generated,
and HIV prevalence decreases to extinction. But the model indicates that an epidemic can be generated by the
amplification effect on HIV transmission caused by co-infection.
Conclusion: The simulated sexual network demonstrated that a single value for HIV infectivity fails to describe the
dynamics of the epidemic. Regardless of the low probability of heterosexual transmission per sexual contact, the
inclusion of individual variation generated by transient but repeated increases in HIV viral load associated with co-
infections may provide a biological basis for the accelerated spread of HIV in sub-Saharan Africa. Moreover, our
work raises the possibility that the natural history of HIV in sub-Saharan Africa cannot be fully understood if
individual variation in infectiousness is neglected.
Background
The cause of the high HIV-1 prevalence in sub-Saharan
Africa is incompletely understood [1-3]. Unlike HIV in the
US and Europe, which seems concentrated among injec-
tion drug users and men who have sex with men [1,2,4],
the epidemic in Africa is more widely distributed across
the general population, with heterosexual penile-vaginal
transmission proposed as the main mechanism [4-7].
Mathematical models are powerful tools in epidemiology:
they can facilitate understanding of the interplay between
the variables that determine the course of infection within
an individual and the variables that control the pattern
of infections within communities of people. But mathema-
tical modeling studies that attempt to reproduce the
observed HIV epidemic curve in sub-Saharan Africa are
often criticized for using per-contact and per-partnership
heterosexual transmission efficiencies that are improbably
high [8,9]. For example in the calculation of per-partner
rate of transmission, behavioral parameters such as number
of sexual partners per year and number of sexual contacts
per partner may be overestimated by assuming levels of
promiscuity in African societies that are too high [8].
Unlike more traditional epidemiological approaches that
focus strictly either on individuals or on populations, sexual
networks are based on the dynamics of the sexual links
(connections between nodes = between individuals) and
the topology of the linkage in a group [10,11]. Sexual net-
works have multiple advantages for characterizing indivi-
dual heterogeneity of sexual behavior. This approach to
understanding the spread of a sexually transmitted infec-
tion (STI) has focused attention on the properties of the
frequency distribution of sexual partner number. In sexual
networks, partner number is the node degree, the number
of sexual links that each node (individual) has to others
[12]. Thus network studies mainly focus on the distribution
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[13].
Network models also focus on other components of the
network structure that cannot be described from the
observation of individual nodes alone. The degree distribu-
tion is only one example of an aggregate statistics obtained
by the study of the individual properties within the net-
work. For the calculation of other statistics, such as the
level of clustering, it would be necessary to observe larger
fragments of the network [14]. Clustering measures focus
on describing both the connections from focal nodes and
the connections made by its neighbors. In particular, high
levels of clustering may reduce the rate of spread of an
infectious disease [15].
The typically high skew of sexual degree distributions
has suggested that sexual networks may follow a power
law (scale-free) distribution [16,17]. Power law distribu-
tions are characterized by many nodes with only one or
few connections but also a few nodes with many more
connections, generating a high contact variance. The high
variance observed in large populations that follow the
power law distributions implies that even very low trans-
mission rates are consistent with disease spread [11,18].
Most of the studies that have attempted to describe sex-
ual behavior in Africa have found that the power law dis-
tribution does not adequately fit the data. Instead, fixed
rate models such as the negative binomial model, which is
a generalization of the Poisson model, appear to fit the
degree distribution best [12,13]. In the negative binomial
model, the propensities of individuals to form connections
are estimated from a gamma distribution. This approach,
with its lower variance in connectedness among nodes,
raises the possibility that the infectivity of HIV may be an
important determinant of the epidemic in sub-Saharan
Africa [10,18].
Yet this conclusion is inconsistent with the low prob-
ability of heterosexual HIV transmission, estimated to be
~ 1/300 per coital act in low income countries [19,20].
Moreover, studies that attempted to estimate the prob-
ability of HIV transmission per sexual contact have
found that the Bernoulli model accurately estimates the
per-partner probability of HIV transmission but does not
seem to correlate with the number of sex acts and thus
fails to estimate the per sexual contact probability of
transmission [21]. It has been suggested that the constant
transmission probability in the Bernoulli model may be
the problem: variability of infectiousness among indivi-
duals and over time, such as may arise from important
transmission cofactors, may be essential for a realistic
representation of HIV transmission [21-23].
Despite the low probability of heterosexual penile-
vaginal transmission per sexual contact, some studies
have demonstrated that the risk of HIV transmission
can be strongly correlated with variation in blood viral
burden [24-26]. The most relevant finding from these
studies is that infectiousness can be directly correlated
with the concentration of HIV-RNA in blood,
which indicates shedding of the virus into genital track
secretions.
In a pioneering study attempting to correlate the viral
load and the transmission of the virus, Quinn et al. [27]
measured the HIV-RNA load in the blood of more than
15000 subjects. They found that the virus was hardly ever
transmitted by infected subjects with less than 1500 copies
of HIV-RNA/ml, whereas individuals with more than
50 000 copies infected their sexual partners at a rate of
23 per 100 person-years over 30 months.
A similar study conducted with discordant couples for
HIV status in Uganda showed the existence of a strong
correlation between HIV plasma viral load and HIV trans-
mission rates [28]. The Uganda study indicated that a ten-
fold increment in viral load could increase the risk of HIV
transmission per sexual contact 2.45-fold (95% confidence
interval 1.85-3.26). They pointed out that although blood
and semen reside in separate biological compartments,
blood viral burden can be correlated with viral burden in
semen.
Growing evidence suggests the existence of additional
biological factors that cause variations in the viral load.
The viral set point is actually not constant and may be
perturbed by reactivations of the immune system, such as
those resulting from the invasion of other pathogens [29].
Changes in the host immune response may account for
variations in the viral load that could make the host more
infectious and increase the risk of transmission.
The average African host is usually exposed to numer-
ous bacterial, viral and parasitic infections. Of special
importance is the very high prevalence of STIs, particularly
genital ulcerations caused by herpes simplex virus type
2 (HSV-2) [29]. The existence of a synergistic relationship
between HIV and HSV-2 has been strongly suggested by
many observational and biological studies in which HSV-2
has been implicated as a biological cofactor for the acqui-
sition and transmission of HIV [30,31].
The rapid spread of HIV as a sexually transmitted dis-
ease is exceeded by that of HSV-2 [32]. The prevalence of
HSV-2, which may be as high as 75% among women in
parts of sub-Saharan Africa [33], has reached a prevalence
of up to 90% in HIV-positive persons [31].
While bacterial STIs such as gonorrhea and syphilis,
which also amplify the risk of HIV transmission [34],
tend to be concentrated in high risk groups [35], the bio-
logical characteristics of HSV-2 allow this virus to be sus-
tainable at high levels in the general population, as
observed in sub-Saharan Africa [36]. Consequently, as
the HIV epidemic reaches the general population, the
epidemiological overlap between HSV-2 and HIV is con-
siderably larger than any other STI.
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bers of CD4+ lymphocytes, the target cell for HIV, and
therefore are likely to facilitate the acquisition of HIV in
HIV-negative individuals [37]. Additionally, the high levels
of HIV-RNA in herpetic lesions from dually infected
patients [38] may be explained by studies in vitro demon-
strating that HSV-2 increases HIV transcription, which
supports the higher infectivity in co-infected individuals.
Population-based studies have also demonstrated that
HIV-RNA levels can increase during active HSV-2 infec-
tion [39], and suppression of HSV-2 with acyclovir was
associated with a measurable decrease on the HIV-RNA
levels [40].
The enhanced HIV infectivity caused by HSV-2 co-
infection has also been corroborated by population-based
studies suggesting a relative risk of three to five-fold of
HIV transmission from co-infected individuals compared
to HSV-2 seronegative persons [36,41,42]. These data sug-
gest that HSV-2 may be playing a key role fueling the HIV
epidemic in sub-Saharan Africa [43].
The activation of the immune system, however, is not
only produced by STIs. Parasitic infections such as hel-
minth infections, leishmaniasis and malaria might produce
a strong response from the immune system and conse-
quently generate similar effects on the replication of the
virus in HIV co-infected individuals [29,44-47]. The geo-
graphical overlap observed between malaria and HIV
infections has suggested a possible interaction influencing
H I Vt r a n s m i s s i o ni ns o m ec o u n t r i e so fs u b - S a h a r a n
Africa. Malaria occurs throughout the tropical world,
where it remains one of the most prevalent infectious dis-
eases, with an estimated 300 million cases per year [48].
The evidence of an interaction between malaria and HIV
comes from various sources. Several in vitro studies have
found that malaria antigens significantly enhanced HIV-1
replication [44-46,49]. Additionally, population-based stu-
dies conducted with HIV-1 infected adults have indicated
that the HIV-1 RNA concentration almost doubled
between baseline (96,215 copies per ml) and those co-
infected with malaria (168,901 copies per ml). The authors
concluded that HIV-positive individuals co-infected with
malaria had a significantly increased viral load and possibly
increased infection transmission [45].
Based on the evidence previously mentioned, this study
examines the limitations of the view that the level of the
HIV epidemic in sub-Saharan Africa could be explained
merely by a constant probability of transmission. We sus-
pected that disregarding the variation across individuals
in HIV infectivity would fail to replicate the HIV epi-
demic observed in a sexual network from sub-Saharan
Africa. Instead, we predicted that individual and temporal
variations in HIV transmission generated by biological
f a c t o r ss u c ha sc o - i n f e c t i o n sw i t ho t h e ri n f e c t i o u sd i s -
eases could explain the severity of the HIV epidemic.
Methods
With the aim of testing the effect of temporal and indivi-
d u a lv a r i a t i o no nH I Vt r a n s m i s s i o ng e n e r a t e db yc o -
infection, we developed a dynamic sexual network model
[15]. Partnership acquisition process relevant to HIV
infections is too complex to be adequately captured by a
static degree distribution [50]. Other nodal attributes
such as gender, age and marital status are also of funda-
mental importance, as are the dynamics of the linkages
themselves. To include these characteristics, we used
Monte Carlo simulations to depict a dynamic sexual net-
work with given nodal and structural characteristics,
where links between nodes are formed and dissolved
according to estimated parameters. The model incorpo-
rates the dynamic of the behavioral components of the
population, as well as the dynamics of HIV and the co-
infection effect on the HIV transmission caused by other
infectious diseases, including HSV-2, gonorrhea, syphilis
and malaria, along with the spread of HIV infections
caused by commercial sex. We used data from studies in
Malawi when available as an example of a generalized
HIV epidemic [51-53].
Model structure
A stochastic, individual-based sexual network model was
created to simulate disease dynamics using the MATLAB
®
computing language version 7 [54]. The model was
divided in two main modules: a behavioral module and an
epidemiological module.
Sexual partnerships were assumed to be exclusively het-
erosexual, and two types of partnerships, distinguished by
duration, were considered. The population size remained
constant, with individuals maturing into the network to
o f f s e tt h o s ew h od i eo rm a t u r eo u to ft h en e t w o r k .I n
accordance with the highest resolution of relevant data, a
monthly time step was used. With this model, the effects
of network structure on disease transmission, relationship
type, and co-infection with other infectious diseases were
evaluated.
For the estimation of the main parameters of the sex-
ual network, data were used from a study of Malawi by
the University of Pennsylvania Population Study Center
and called “The Malawi Social Network Project” [51], as
well as data from the Demographic and Health Survey
(DHS) database from Malawi [55]. The study was con-
ducted in three districts of Malawi, and the sampling
strategy is explained elsewhere [52,53]. The study
focuses on the description of the sexual behavior in the
Malawi population, where the more important charac-
teristics such as age distribution, number of sexual part-
ners per year, type of relationship, duration of the
relationship and age mixing patterns of marriage were
derived. Additional file 1, Table S1 lists the key assump-
tions of the behavioral module.
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and assigned an age and node degree (maximum num-
ber of partners per year). Consequently, individual age
was used to determine when individuals should be
removed from the sexual network and was the basis for
other age-specific traits.
The epidemiological module was subdivided into two
steps, the spread of the infections, and the progression
and recovery of each infection. We selected gonorrhea
and syphilis as examples of bacterial STIs concentrated
in the high-risk (core) groups based on the amplification
effect on HIV transmission, and their relevance in terms
of prevalence in the Malawi population [56,57]. The
dynamics of these infections are well known, and the
effect of each infection on the transmission of HIV has
been determined.
We also included two infections with high prevalence in
the general population: herpes simplex virus type 2 (HSV-
2) and malaria. The chronic nature of HSV-2 and its rela-
tively high transmission efficiency make it sustainable in
the general population. HSV-2 reactivations increase HIV
transcription [58], which in turn generates an increase in
the HIV plasma viral load [59] and supports higher HIV
infectivity in dually infected individuals [27]. The evidence
suggests an epidemiologic synergy between both diseases,
and HSV-2 has been postulated as the most important
STI driving the HIV prevalence in sub-Saharan Africa
[43].
We included malaria as an example of a parasitic infec-
tion, given its geographical overlap with HIV and its high
prevalence in Malawi. Malaria is endemic in all parts of
Malawi and many other countries in sub-Saharan Africa.
According to The World Health Organization, 6 million
of episodes of malaria occurred in 2006, accounting for
about 33% of all outpatient visits in Malawi. Additional
file 1, Table S2 lists the key assumptions of the epidemio-
logical module.
A key assumption for the epidemiological module is that
the interaction caused by co-infection has only one direc-
tion. In other words, we assumed that HIV infection has
no effect on the natural history of the other infectious dis-
eases included in the model. This assumption may be seen
as an oversimplification because studies have shown that
HIV infection affects the transmission and progression of
other infectious diseases such as HSV-2 and malaria. Yet,
studies have mainly focused on the impact of co-infection
on HIV. As a result, uncertainty about the effect of co-
infection on the other diseases is still high.
The core of our model is the spread of HIV infection
through penile-vaginal contact. Before the introduction
of HIV infected individuals, the model simulates for sev-
eral months the dynamic of the other infectious diseases
previously mentioned. When an endemic steady state for
all infectious diseases is reached (after about 500 monthly
time steps), the model introduces HIV infected indivi-
duals until the HIV prevalence reaches 1%, which is the
prevalence observed in Malawi in 1981 [60].
For our simulation, the algorithm assessed whether
the individual infected with HIV has another infectious
disease, and if co-infection was present, the HIV trans-
mission probability was increased depending on the
amplification factor. Then, the new HIV transmission
probability including the amplificatory effect was calcu-
lated by
Tc = T ∗ cofactor.
where T is the stage and sex-specific transmission
probability per sexual contact (Additional file 1, Table
S2). The HIV transmission probability per partnership
per month is then calculated using the binomial
(Bernoulli) model as
Tp =1− (1 − Tc)cn,
where Cn is the number of sexual contacts the indivi-
dual has with the partner.
Cofactor values of the STI’s included in the model
were obtained from population-based estimations
expressed as odds ratios and relative risk per sexual con-
tact. For malaria, we assume that the enhancement on
the transmission probability per sexual contact depends
on the logarithmic (base 10) incremental change in the
viral load according to Tc = T ∗ 2.45log10(vl) . The 2.45
factor is the rate ratio increase in transmission probabil-
ity with each one-log increment in viral load [27], and
log10 (vl) is the logarithmic (base 10) increment of the
plasma viral load; see [45] for malaria increment data.
Cofactor values included in the model are listed in
Additional file 1, Table S2.
When multiple co-infections are present, we assumed
a saturation effect of the enhancement on the transmis-
sion probability. Thus, when more than one co-infection
is present, the transmission probability is amplified only
by the highest cofactor. For the special case of HSV-2,
the amplification factor is only effective if the HSV-2
infection is reactivated (shedding) [37,61]. Therefore, the
algorithm not only verifies the presence of HSV-2 co-
infection but also its reactivation. On the other hand,
HSV-2 not only enhances the transmissibility of HIV
but also affects the susceptibility to being infected with
HIV [61]. For this reason, the algorithm verifies if the
susceptible receptor is infected with HSV-2 and its reac-
tivation stage. In this case, the transmission probability
is also increased by the respective amplification factor.
A detailed description of the methodology can be found
in the Additional file 1, Text S1.
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HIV infections caused by co-infection with other infec-
tious diseases may also generate secondary HIV infec-
tions, regardless of the presence of co-infection [43].
Therefore, the HIV prevalence measures both the HIV
transmissions caused by the direct biological effect of co-
infection and the secondary or indirect infections caused
by co-infection. We estimated the effect of co-infection
on the dynamic of the HIV epidemic in the sexual net-
work by comparing the prevalence for different scenarios:
no co-infection, all co-infections (default scenario), no
HSV-2 co-infection, and no malaria co-infection. We
also measured the direct effect of co-infection on the
HIV incidence by using population attributable fractions
(PAF) [62-64]. We estimated the PAF of HIV incidence
attributable to all co-infections, HIV-2, malaria, and
gonorrhea and syphilis. The PAF is calculated by
PAF(t)=

1 −
IRnocofactor(t)
IRdefaultcofactor(t)

× 100%,
where IR nocofactor (t) is the incidence rate of HIV in
the different scenarios with the cofactor effect removed
at time t,a n dIR defaultcofactor (t)i st h eH I Vi n c i d e n c e
rate with the default cofactor effect at time t [43,65].
To identify the epidemiologic synergy at different peri-
ods of the HIV epidemic, we calculated the PAF for dif-
ferent time points in a separate set of simulations by
removing the cofactor effect on HIV transmission over
two years, starting at times (t) 0, 8, 15, and 20 after the
introduction of HIV. This allows us to measure of the
direct role of co-infection in HIV incidence at each time
point (t). Results from all different scenarios are based
on means over 200 simulations.
Uncertainty and sensitivity analyses of the key
parameters
To conduct uncertainty and sensitivity analyses of the
key parameters, we adopted the Latin Hypercube Sam-
pling/Partial Rank Correlation Coefficient (LHS/PRCC)
technique [66,67]. In LHS, the estimation of uncertainty
for each key parameter is modeled by treating each input
parameter as a random variable with a uniform probabil-
ity distribution function. Upper and lower bounds on
these distributions were assigned based upon the avail-
able data.
To study the uncertainty of the parameters for the two
different modules, we conducted three different uncer-
tainty analyses. For the behavioral module, the simulations
did not include the amplification cofactor caused by co-
infection. Hence, we used the default probability of HIV
transmission T=0.003 and we performed a LHS of the
more important behavioral parameters. For the epidemio-
logical module, the simulations included the amplification
co-factor caused by confection and we conducted a LHS
of the cofactor values. In the third uncertainty analysis, we
performed a LHS of both the behavioral parameters and
the cofactor values. 200 simulations were run for each
uncertainty analysis. The variability in the outcome vari-
able (HIV prevalence) was then estimated by simple
descriptive statistics. Sensitivity analyses were then per-
formed by calculating PRCCs for each input parameter.
The details of these analyses can be found in the Addi-
tional file 1, Text S2.
Results
Sexual network
The graphical representation of the degree distribution
(i.e. number of sexual partners per year) for both males
and females shows that the gamma distribution provides a
good fit to the data (Additional file 1, Figure S1). For
males, the mean number of sexual partners per year was
μ = 2.12, with standard deviation SD = 1.23, and with a
scale parameter θ = 1.1 and shape parameter k =1 . 9f o r
the gamma distribution. For females, the mean number of
sexual partners per year was μ = 1.84 with standard devia-
tion SD = 1.04, and with scale parameter θ =0 . 4a n d
shape parameter k = 3.8 (Additional file 1, Table S1).
The resulting number of sexual partners per year
obtained from the simulations for both males and females
seems to agree with the estimated annual degree distribu-
tion from Malawi (Additional file 1, Figure S1), the age
distribution of the entire population (Additional file 1, Fig-
ure S2), and the age distribution of married individuals
(Additional file 1, Figure S3). We found, however, that
individuals accumulated more long-term relationships
(marriages) throughout their entire sexual life than indi-
cated by the data (Additional file 1, Figure S4). This incon-
sistency could result from a low estimate of the average
duration of marriage (~7 years) in the simulations.
Since long-term relationships increase the number of
exposures, the risk of transmission or acquisition of the
virus also increases. Consequently, the observed discre-
pancy between the lifetime number of long-term relation-
ships observed in the simulations and the data may
generate an overestimation of the HIV prevalence.
Using the number of connections per month (see
Additional file 1, eq. 9) and the number of connections
generated by individuals who already have one connec-
tion, we found that the frequency of concurrency esti-
mated from the model was 0.3. In other words, 30% of
the individuals who had a sexual partner were in at
least one concurrent relationship. This value seems to
be consistent with some estimates of concurrency from
sub-Saharan Africa [68]. See also [69], where the con-
currency estimate was higher, but concurrent relation-
ships were not clearly distinguished from serial
monogamy [70].
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The first simulation, which included the most recent
estimate of the male-to-female probability of HIV trans-
mission T = 0.003 [20], suggests that with this constant
probability of HIV transmission the infection does not
survive in the population: no epidemic can be generated,
and HIV prevalence decreases to extinction (Figure 1).
On the other hand, with T = 0.005 we observed that the
infection can persist and reached an endemic steady
state at a prevalence equal to the initial prevalence (1%).
Finally, with a T = 0.0068 we could generate an epi-
demic curve similar to the HIV epidemic observed in
Malawi (Figure 1). This value is slightly above the 95%
confidence interval estimated for male-to-female prob-
ability of HIV transmission [20] (see details in Addi-
tional file 1, Text S2).
Simulation 2: amplification cofactor
For this simulation, we used the baseline probability of
HIV transmission for low income countries T =0 . 0 0 3
[20], but we also included the amplification cofactor for
HIV transmission generated by co-infection with HSV-2,
gonorrhea, syphilis and malaria. The results from this
scenario showed that the amplification effect caused by
co-infection was sufficient to generate an HIV epidemic
curve similar to the curve observed in Malawi (Figure 2B,
HIV prevalence estimated for 2005 ~17%).
From our model, we observed that the prevalence for
gonorrhea (~2%), syphilis (~4%), HSV-2 (~40%) and
malaria prevalence in dry (30%) and rainy (40%) seasons
resemble the prevalence observed for these STIs in
Malawi and other countries of sub-Saharan Africa
(Figure 2A) [60,71-77].
Even when parameter values of the model were obtained
independently of the Malawi data, our results resemble the
HIV prevalence as well as the age distribution prevalence
o b s e r v e di nt h a tc o u n t r y .A sr e p o r t e di nt h ed a t a ,t h e
female HIV prevalence was higher than the male preva-
lence; the resulting age distribution of prevalence, how-
ever, differs somewhat from the distribution reported for
Malawi. In our results, the peak of the prevalence is
located at ages 25-29 for both males and females, while
the data suggest that the peak is at ages 30-34. The model
also overestimates the HIV prevalence at early ages (Addi-
tional file 1, Figure S5 A, B).
We compared the simulated age distribution of HSV-2
prevalence with the observed prevalence in Malawi. The
age distribution for HSV-2 obtained from the simulation
is consistent with the data, but the resulting HSV-2 preva-
lence is somewhat lower than the prevalence observed in
Malawi (Additional file 1, Figure S5 C, D).
Our results also showed that more than 40% of the
HIV infections were associated with HSV-2 co-infection
(Figure 3A), and more than 70% of the total HIV trans-
missions were associated with STI or malaria co-infection
(Figure 3C). Significantly, these values indicate that trans-
mission was commonly by co-infected individuals, but
t h er e s u l t sd on o te s t i m a t et h ei n c i d e n c eo fH I Vd u et o
the direct effect of co-infection.
Simulation 3: No HIV-HSV-2 co-infection
Because HSV-2 was the most important infectious disease
in terms of co-infected individuals who transmitted the
HIV infection (Figure 3A), we simulated the absence of the
amplificatory effect generated by HSV-2. For this simula-
tion, the prevalence decreased to ~6% in comparison with
the prevalence observed in simulation 2 (Figure 4A).
Simulation 4: No HIV-malaria co-infection
Without the malaria amplification effect, the HIV preva-
lence declined to ~10%, indicating that malaria contribu-
ted ~7% to the overall HIV prevalence (Figure 4B). This
result is higher than the result obtained by Abu-Raddad
and coworkers [78], who simulated the co-infection effect
of malaria on HIV infection in Kisumu, Kenya, using a sys-
tem of differential equations. They found that excess of
HIV prevalence caused by malaria was 2.1%.
Population Attributable Fraction (PAF)
The results indicated that the proportion of new HIV
infections due to all co-infections together was > 50% and
that this value remained constant over time (Figure 5A).
When we obtained the PAF for each infection, however,
we observed different patterns throughout the simulation.
Figure 1 HIV epidemic curves with constant probability of HIV
transmission (no co-infection).A tT = 0.003 no epidemic can be
generated, and HIV prevalence decreases leading to extinction
(prevalence estimated for 2010 = 0%)). With a T = 0.005 the
infection can persist and reached and endemic steady state at a
prevalence equal to the initial prevalence (HIV prevalence estimated
for 2010 = 1%). At T = 0.0068 the epidemic curve generated is
similar to the HIV epidemic observed in Malawi (HIV estimated
prevalence for 2010 = 10%).
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gonorrhea and syphilis had the highest PAF (~26%). Over
time, their influence on the spread of HIV decreased to a
final PAF of 13%, 20 years after the introduction of HIV
(Figure 5B). In contrast, common infections in the general
population such as malaria and HSV-2 had a low initial
PAF (~12%), followed by an increase. In agreement with
previous studies [43,79] we found that the PAF due to
HSV-2 increases during the first 10 years and then
remained constant after 15 years from HIV introduction
at the highest PAF (~30%).
Likewise, the proportion of new HIV infections caused
by malaria increased during the early years of the epi-
demic, and then remained constant after 15 years from
HIV introduction, with a PAF of ~ 25% (Figure 5B); this
value is in close agreement with previous results for
eastern sub-Saharan Africa based on regression analysis
[80].
Discussion
Our results indicate that a data-supported fixed value
for HIV infectivity fails to describe the dynamics of the
epidemic. Regardless of the low probability of heterosex-
u a lt r a n s m i s s i o np e rs e x u a lc o n t a c t ,t h ei n c l u s i o no f
individual variation in HIV infectivity generated by tran-
sient but repeated increases in HIV viral loads asso-
ciated with co-infections may substantially increase the
transmission rate [25].
Our model thus suggests that the HIV epidemic in
sub-Saharan Africa may be explained by heterosexual
transmission, and supports the hypothesis that variation
among individuals and through time caused by biologi-
cal cofactors such as co-infection may have triggered
the vast HIV epidemic observed in sub-Sahara Africa.
The high prevalence of infectious diseases such as
malaria and HSV-2 probably provided suitable condi-
tions for the spread of the infection in the general
population.
The remarkably high HIV prevalence observed in sub-
Saharan Africa may thus reflect the particular environ-
ment at the early and mature stages of the epidemic that
are unique to this part of the world [43]. These results
highlight the possibility that co-infection is a necessary
rather than merely a contributing factor in the successful
spread and survival of HIV in populations where hetero-
sexual vaginal-penile contact is the main mechanism of
transmission.
According to our results, 50% of all new HIV infections
throughout the epidemic can be attributed to co-infection
with the infectious diseases included in the model. How-
ever, we observed opposite time trends in the contribution
from two infections with low prevalence in the general
population (i.e. decreasing trends for gonorrhea and syphi-
lis), and from infections with high prevalence (i.e. increas-
ing trends for HSV-2 and malaria).
Some similar results have been obtained in previous
studies [43,65,79], but none has documented the pattern
in PAF that we observed for malaria throughout the epi-
demic. Our model is the first to include not only the co-
factor effect of other STIs on HIV transmission but also
the co-factor effect of a parasitic disease in the same
simulation. The expected high frequency of malaria-HIV
Figure 2 Time course of HIV with the inclusion of the amplification effect caused by co-infection (simulation 2). In (A), the dynamics
of HSV-2, syphilis, gonorrhea and malaria were simulated and allowed to approach steady state before the introduction of HIV into the
population. Once endemic steady states of these infections were reached, 1% of individuals were infected with HIV, and HIV established in
the population. (B) shows in more detail the time course of HIV in Malawi simulated by the inclusion of the amplification effect generated
by co-infection (Simulation 2). The measured HIV prevalence from Malawi, for both males and females in general population, was extracted
from several studies [91].
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Page 7 of 13co-infected individuals who transmitted the HIV infec-
tion (Figure 3A) raises the possibility that parasitic dis-
eases like malaria with high prevalence in Africa, may be
playing a similar role to that of an STI like HSV-2 in
terms of new HIV infections. This similarity should be
greatest in populations with a mature HIV epidemic and
where both infections overlap geographically. Despite the
low co-factor effect on HIV transmission generated by
malaria, the high prevalence of this infection may have
increased its effect on the HIV incidence as the HIV epi-
demic has invaded the general population.
Our analysis suggest that the synergy among sexually
transmitted infections and parasitic infections allowed
the HIV epidemic to reach the general population,
which may not have been possible without the cofactor
effect on HIV transmission generated by co-infection
[ 4 3 ] .T h i si nt u r ns u g g e s t st h a ta nH I Ve p i d e m i cm a y
be mitigated or halted through measures that decrease
Figure 3 Fraction of new infections when the HIV infectious (transmitter) individual has a co-infection (simulation 2). The model tracks
the mechanism of the transmission of the infection. For the simulated period, if an HIV infection takes place, we recorded the presence in the
infectious individual of any of the four infectious diseases included in the model, or in the case of HSV-2 due to the enhanced susceptibility
caused by HSV-2 infection, we also recorded the presence of this infection on the susceptible individual and identified the cause of the
amplification of the transmission caused by co-infection. (A) shows that HSV-2 was the most prevalent infection in co-infected individuals who
transmitted the HIV infection, followed by malaria. This result is associated with the high prevalence of both infections in the general population.
Grouping all STIs, more than 50% of the HIV infections were associated with an STI (B). More than 70% of the total HIV infections were caused
by co-infected individuals (C).
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Page 8 of 13viral infectivity. The control and treatment of several
common infectious diseases could decrease the inci-
dence of HIV over the long-term.
Although interventions aimed at reducing the inci-
dence of STIs have a prominent place in control strate-
gies, some studies have failed to show an impact of STI
treatments on HIV incidence [81,82]. Some authors
have suggested that population differences in sexual
behavior, differences in STI prevalence and the stage of
the HIV epidemic may explain the poor impact of this
control intervention [83]. These studies [81,82] com-
monly focused on STIs with low prevalence in the
general population, such as syphilis, trichomoniasis,
gonorrhea and chlamydia.
However, as our study and other studies [40,84,85]
have indicated, infectious diseases present in the general
population such as HSV-2 and parasitic diseases have
the highest impact on the HIV incidence in mature HIV
epidemics. A transmission study conducted to determine
whether HSV-2 suppression in HIV/HSV-2 co-infected
individuals reduces the risk of HIV transmission indicated
that, despite a notorious reduction in the prevalence of
genital ulcer diseases generated by HSV-2, and a 0.25 log10
copies/ml reduction in plasma HIV-RNA levels, HSV-2
suppression with acyclovir did not prevent HIV transmis-
sion [86]. In a subsequent work, however, Lingappa et al.
demonstrated that a 0.74 log10 copies/ml reduction in HIV
plasma RNA concentration is necessary to reduce the HIV
Figure 4 Removing the amplification effect on HIV transmission. (A) shows the time course of HIV when HSV-2 does not have an
amplification effect on HIV (simulation 3) and the prevalence for 2005 decays to ~6% (C). In the scenario where malaria does not have an
amplification effect on HIV transmission (simulation 5), the resulting prevalence decays to ~10% (B).
Figure 5 Population Attributable Fraction (PAF) due to co-infection. We measured the direct effect of co-infection on the HIV incidence by
using the population attributable fractions. (A) The PAF due to co-infection in general, and (B) the PAF due to HSV-2 (solid line), syphilis and
gonorrhea (dotted line) and malaria (dashed line).
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Page 9 of 13transmission rate by half [87]. HSV-2 suppression with
acyclovir may thus have been insufficient to yield a detect-
able reduction in HIV transmission risk. Lingappa et al.
concluded that treatment of co-infections capable of redu-
cing plasma HIV levels by > 0.7 log10 copies/ml may be a
valuable tool for suppressing the transmission of HIV.
Limitations of the model
The results of this study derive from a simulation model
and depend on the validity of the underlying assump-
tions and parameter magnitudes. Uncertainties about
the magnitudes of these parameters suggest that the
conclusions presented here should be interpreted with
caution. HIV transmission pro b a b i l i t ya n dt h ee f f e c to f
behavioral and biological cofactors on HIV transmission
require more thorough quantification [43,65,79], and we
hope that our results will help motivate this work.
Additionally, cofactor values are commonly estimated
from population-based observations of co-infection status
in individuals or couples [88]. In these cases, the associa-
tion between the transmission of HIV and the presence of
an STI is generally expressed in terms of odd ratios,
hazard ratios or relative risk per sexual contact [89]. These
estimates, however, can be particularly difficult to interpret
as a consequence of multiple potential biases.
To reduce confounding effects resulting from other
behavioral and biological risk factors, estimates of cofactor
effects are statistically adjusted for the influence of these
risk factors. But these analyses may not completely control
for the confounding effects because STIs, HIV and other
behavioral and biological risk factors may cluster not only
in study subjects but also in the unknown partners of the
individuals included in the study [88]. Moreover, the con-
founding generated by the characteristics of the sexual
network such as concurrency, mixing patterns and num-
bers of sexual partners is virtually impossible to control
for completely [88].
On the other hand, the high variation in HIV preva-
lence produced by the model observed in the uncertainty
analysis compromises the accuracy of the model’s predic-
tions (Additional file 1, Table S9). The sensitivity analysis
indicated that the model is highly sensitive to the beha-
vioral parameters that influenced the per-partner prob-
ability of HIV transmission, such as the average duration
of casual relationships and the mean number of sexual
contacts, and to the biological parameters responsible for
the cofactor effect of infections present in the general
population, such as malaria and HSV-2 (Additional file 1,
Table S10). Thus, efforts focused on more precise estima-
tions of these parameters will improve the accuracy of
predictions from models exploring the causes of the HIV
epidemic in sub-Saharan Africa.
Lastly, the model assumes that HIV is transmitted
exclusively by penile-vaginal heterosexual contact, and
thus the model does not include anal intercourse as a
mechanism of HIV transmission. Since anal intercourse
increases the probability of transmission [20], this type
of sexual behavior has been proposed as an important
risk factor of HIV transmission. Although many authors
claim that heterosexual penile-vaginal contact is the
main mechanism of transmission in sub-Saharan Africa,
more of information about the frequency of anal inter-
course, including men who have sex with men, would
allow an evaluation of this possibly important but little-
studied mechanism of transmission in the epidemic in
sub-Saharan Africa [90].
Conclusions
The present study shows that the natural history of HIV in
sub-Saharan Africa cannot be fully understood if indivi-
dual variation in infectiousness is neglected. Our model
suggests that a single value for HIV infectivity fails to
describe the dynamics of the epidemic. Regardless of the
low probability of heterosexual transmission per sexual
contact, the inclusion of temporal and individual variation
generated by transient increases in HIV viral loads asso-
ciated with co-infections may provide a biological basis for
the accelerated spread of HIV in sub-Saharan Africa.
Our findings have direct implications on the design of
mathematical models attempting to replicate the epi-
demic curve observed in sub-Saharan Africa, as well as
control interventions focusing on decreasing the inci-
dence of HIV. If highly infectious individuals can be iden-
tified, then the efficiency of control measures could be
greatly increased. The realization of these kinds of tar-
geted interventions, however, requires a better under-
standing of factors determining individual infectiousness
such as co-infections.
Additional material
Additional file 1: Supplementary material. A single PDF file. 31 pages
that include supplementary methods, and supplementary results. The
supplementary tables and figures are embedded in the file.
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